• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

covid19.healthcare.pro
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home DermConnect Example CLIN

Tag Archive

  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    Factors ID’d for Strong Antibody Response in COVID-19

    View Post
  • COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    COVID-19 Pandemic Challenges Osteoporosis Management

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 26, 2020

    AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy / October 23, 2020

    Survival From COVID-19 High in Patients With Psoriasis

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 23, 2020

    FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    View Post
View Post

Females, Some Minorities Underrepresented in COVID-19 Clinical Trials

In COVID-19, Latest News
by Healthday
December 13, 2022

Females underrepresented in treatment trials, while Asian, Black participants underrepresented in prevention trials

View Post

Preprint, Peer-Reviewed Pairs of Studies Generally Concordant

In COVID-19, Latest News
by Healthday
December 12, 2022

Sample sizes, primary end points, interpretations mainly concordant for studies published on medRxiv, then in journals

View Post

FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’

In COVID-19, Latest News
by Healthday
November 17, 2022

Article describes inadequate oversight relating to development of COVID-19 vaccines and predating the pandemic

View Post

NIH Investigating COVID-19 Experiments Conducted at Boston University

In COVID-19, Latest News
by Healthday
October 19, 2022

WEDNESDAY, Oct. 19, 2022 (HealthDay News) — The U.S. National Institutes of Health is investigating COVID-19 experiments at Boston University that have sparked a media firestorm, with some news outlets …

View Post

Disruption to Oncology Clinical Trials Seen Early in Pandemic

In COVID-19, Latest News
by Healthday
June 15, 2022

Numbers of new patient accruals and newly activated trials decreased early on, followed by progressive recovery

View Post

Another HIV Vaccine Trial Canceled Due to Poor Results

In COVID-19, Latest News
by Healthday
September 2, 2021

Cancellation is the latest in a string of failures for HIV vaccine research

View Post

Enrollment in Cancer Treatment Trials Largely Unchanged by Pandemic

In COVID-19, Latest News
by Healthday
August 4, 2021

However, there was a significant decrease in enrollment for cancer control and prevention trials

View Post

Should Changes Made to Clinical Trials During Pandemic Be Kept?

In COVID-19, Latest News
by Healthday
July 22, 2021

Changes were recommended to preserve potential patient benefit while minimizing risks associated with COVID-19

View Post

NIH Starts Trial Assessing ‘Mix & Match’ COVID-19 Vaccine Approach

In COVID-19, Latest News
by Healthday
June 2, 2021

Individuals who received J&J, Moderna, or Pfizer-BioNTech vaccine will receive single booster dose of Moderna vaccine 12 to 20 weeks later

View Post

NIH Halts Trial of Convalescent Plasma for Mild COVID-19

In COVID-19, Latest News
by Healthday
March 3, 2021

While the treatment seemed safe, no significant differences in outcomes were seen between patients receiving convalescent plasma or placebo

  • Page 1 of 2
  • 1
  • 2
  • →

TRENDING

  • Pattern of Early Identification of Autism Reversed After Pandemic
  • Tuberculosis Patients Increasing 5% in the U.S.
  • Is Kentucky Protected from Measles
  • 1.9 million Children Receiving Yellow Fever Vaccination
  • More Testing of Staff Linked to Drop in COVID-19 Cases, Deaths at SNFs

By Publish Date

March 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Feb    

LATEST ARTICLES

  • Pattern of Early Identification of Autism Reversed After Pandemic March 24, 2023
  • Tuberculosis Patients Increasing 5% in the U.S. March 23, 2023
  • Is Kentucky Protected from Measles March 23, 2023

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines